We are hiring! Click to View Open Positions.

Posters & Presentations

November 2024

Society for Immunotherapy of Cancer (SITC) 2024

DRAGON trial: durable remission rate with the latent TGFβ1 inhibitor linavonkibart (SRK-181) and pembrolizumab in patients with immune checkpoint inhibitor–resistant advanced cancers

View This Poster

November 2024

ObesityWeek 2024

SRK-439 Selectively Inhibits Myostatin to Promote Healthy Body Composition During Metformin Therapy

View This Poster

October 2024

World Muscle Society Annual Congress

Longer-term efficacy, safety, and patient-reported outcomes of apitegromab in patients with nonambulatory SMA: Results from the 48-month TOPAZ study

View This Poster

October 2024

World Muscle Society Annual Congress

Apitegromab in spinal muscular atrophy: Baseline characteristics of participants enrolled in the phase 3 SAPPHIRE study

View This Poster

June 2024

American Diabetes Association Scientific Sessions

The Anti-Myostatin Antibody SRK-439 Promotes Healthy Body Composition in Combination with GLP-1RAs in a Mouse Model of Obesity

View This Presentation

June 2024

Cure SMA Annual Conference

An Update on Scholar Rock’s Progress in SMA

View This Poster